Coriat P, Eyraud D
Service d'anesthésie-réanimation, hôpital Pitié-Saipêtrière, Paris.
Arch Mal Coeur Vaiss. 1998 Aug;91 Spec No 4:17-22; discussion 29-30.
The frequency, the nature and physiopathological mechanisms of cardiac complications of general surgical patients are well known. Acute myocardial infarction, the main complication, occurs in 3 to 5% of high risk cases. Though usually subendocardial and asymptomatic, it jeopardizes short and medium term survival of patients. It occurs in the first 48 hours after surgery in the majority of cases, the diagnosis being confirmed by increased serum troponine I levels. The circulatory, mechanical and inflammatory changes and hypercoagulability, which are present during the perioperative period, interact, disturbing the energetic equilibrium of the myocardium and causing episodes of myocardial ischaemia which, if prolonged, result in necrosis of the subendocardial myocardium. These effects must be taken into consideration if the operative risk of coronary patients is to be reduced. It is essential to monitor the haemodynamic parameters which affect myocardial energy consumption both during and after surgery. Particular attention must be paid in the postoperative period which is characterised by metabolic stress and sympathetic hyperreactivity which predispose to prolonged episodes of silent myocardial ischaemia. Betablockers, which effectively prevent per and postoperative ischaemia without causing jeopardy to the haemodynamic status and which reduce the cardiac risk of general surgery have a role to play in the prevention of acute myocardial infarction in the postoperative period when prescribed before surgery and continued by oral administration during the first 6 postoperative days. The alpha-2-agonists affect sympathetic reactivity during and after surgery and are very well tolerated haemodynamically. If the current on-going multicenter trials show that they prevent postoperative cardiovascular complications, they could be prescribed prophylactically in patients at risk.
普通外科患者心脏并发症的发生率、性质及病理生理机制已为人熟知。急性心肌梗死是主要并发症,在高危病例中发生率为3%至5%。虽然通常为心内膜下梗死且无症状,但它会危及患者的短期和中期生存。大多数病例发生在术后48小时内,血清肌钙蛋白I水平升高可确诊。围手术期出现的循环、机械和炎症变化以及高凝状态相互作用,扰乱心肌的能量平衡,导致心肌缺血发作,若持续时间延长,则会导致心内膜下心肌坏死。若要降低冠心病患者的手术风险,就必须考虑这些影响。在手术期间及术后监测影响心肌能量消耗的血流动力学参数至关重要。术后阶段必须特别关注,此阶段的特点是代谢应激和交感神经反应性亢进,易引发长时间的无症状心肌缺血发作。β受体阻滞剂可有效预防围手术期和术后缺血,且不会危及血流动力学状态,还能降低普通外科手术的心脏风险,在术前给药并在术后头6天口服持续使用时,对预防术后急性心肌梗死有作用。α-2激动剂会影响手术期间及术后的交感神经反应性,且血流动力学耐受性良好。如果正在进行的多中心试验表明它们能预防术后心血管并发症,那么可对有风险的患者进行预防性给药。